Publication | Closed Access
LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program
41
Citations
0
References
2015
Year
Hcv Genotype 3Interim AnalysisViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyChronic Viral InfectionInfection ControlAntiviral DrugMedicineClinical MicrobiologyEpidemiology
No additional data available for this publication yet. Check back later!